The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Global geographic trends in antimicrobial resistance: the role of international travel
Open accessAbstract
Background: Rising antimicrobial resistance (AMR) is a threat to modern medicine, and increasing international mobility facilitates the spread of AMR. Infections with resistant organisms have higher morbidity and mortality, are costlier to treat, result in longer hospital stays and place a greater burden on health systems than infections caused by susceptible organisms. Here we review the role of travel in the international dissemination of AMR and consider actions at the levels of travelers, travel medicine practitioners and policymakers that would mitigate this threat. Results: Resistant pathogens do not recognize international borders; travelers to areas with high AMR prevalence are likely to be exposed to resistant bacteria and return to their home countries colonized. Medical tourists go between health facilities with drastically different rates of AMR, potentially transmitting highly resistant strains. Drug-resistant bacteria have been found in every continent; however, differences between countries in the prevalence of AMR depend on multiple factors. These include levels of antibiotic consumption (including inappropriate use), access to clean water, adequate sanitation, vaccination coverage, the availability of quality healthcare and access to high-quality medical products. Conclusions: Travelers to areas with high levels of AMR should have vaccines up to date, be aware of ways of treating and preventing travelers’ diarrhea (other than antibiotic use) and be informed on safe sexual practices. The healthcare systems of low- and middle-income countries require investment to reduce the transmission of resistant strains by improving access to clean water, sanitation facilities and vaccines. Efforts are needed to curb inappropriate antibiotic use worldwide. In addition, more surveillance is needed to understand the role of the movement of humans, livestock and food products in resistance transmission. The travel medicine community has a key role to play in advocating for the recognition of AMR as a priority on the international health agenda. Key policy recommendations: AMR is a threat to modern medicine, and international travel plays a key role in the spread of highly resistant strains. It is essential that this is addressed at multiple levels. Individual travelers can reduce antibiotic consumption and the likelihood of infection. Travelers should have up-to-date vaccines and be informed on methods of preventing and treating travelers’ diarrhea, other than use of antibiotics and on safe sexual practices, such as condom use. Healthcare facilities need to be aware of the travel history of patients to provide appropriate treatment to those who are at high risk of exposure and to prevent further spread. Internationally, in countries without reliable and universal access to clean water, sanitation and hygiene, investment is needed to reduce the emergence and spread of resistance and ensure the antimicrobials available are of assured quality. High-income countries must ensure their use of antimicrobials is appropriate to reduce selection for AMR. Surveillance across all countries is needed to monitor and respond to this emerging threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationOutpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Self-citationKumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Self-citationLogan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Global Epidemiology of Campylobacter Infection
Kaakoush, N. O., Castaño-Rodríguez, N., Mitchell, H. M., & Man, S. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-15 · Cited by 1,529
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationMu, J., Wang, G., Yan, H., Li, H., Wang, X., Gao, E., Hou, C., Pham, A. T. C., Wu, L., Zhang, Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03032-2 · Cited by 1,436
Plasmids and the spread of resistance
Carattoli, A. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.001 · Cited by 1,024
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70189-4 · Cited by 851
Self-citationIncreasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Bevan, E. R., Jones, A. M., & Hawkey, P. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx146 · Cited by 791
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
Self-citationWoerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Ewers, C., Bethe, A., Semmler, T., Guenther, S., & Wieler, L. H. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03850.x · Cited by 677
The global distribution and spread of the mobilized colistin resistance gene mcr-1
Wang, R., van Dorp, L., Shaw, L. P., Bradley, P., Wang, Q., Wang, X., Jin, L., Zhang, Q., Liu, Y., Rieux, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03205-z · Cited by 662
Multidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
Willems, R. J. L., Top, J., van Santen, M., Robinson, D. A., Coque, T. M., Baquero, F., Grundmann, H., & Bonten, M. J. M. (2005) · Emerging Infectious Diseases · doi:10.3201/1106.041204 · Cited by 558
Wong, V. K., Baker, S., Pickard, D. J., Parkhill, J., Page, A. J., Feasey, N. A., Kingsley, R. A., Thomson, N. R., Keane, J. A., Weill, F.-X., et al. (2015) · Nature Genetics · doi:10.1038/ng.3281 · Cited by 471
Arcilla, M. S., van Hattem, J. M., Haverkate, M. R., Bootsma, M. C. J., van Genderen, P. J. J., Goorhuis, A., Grobusch, M. P., Lashof, A. M. O., Molhoek, N., Schultsz, C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30319-x · Cited by 462
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., & Mylonakis, E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw283 · Cited by 453
The genetic basis of the fitness costs of antimicrobial resistance: a meta‐analysis approach
Vogwill, T., & MacLean, R. C. (2015) · Evolutionary Applications · doi:10.1111/eva.12202 · Cited by 443
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology
Tenover, F. C., & Goering, R. V. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp241 · Cited by 441
Johnson, A. P., & Woodford, N. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.052555-0 · Cited by 411
The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
Molton, J. S., Tambyah, P. A., Ang, B. S. P., Ling, M. L., & Fisher, D. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit020 · Cited by 342
Kantele, A., Laaveri, T., Mero, S., Vilkman, K., Pakkanen, S. H., Ollgren, J., Antikainen, J., & Kirveskari, J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu957 · Cited by 316
Antimicrobial resistance and management of invasive Salmonella disease
Kariuki, S., Gordon, M. A., Feasey, N., & Parry, C. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.102 · Cited by 309
Nordmann, P., Poirel, L., Toleman, M. A., & Walsh, T. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq520 · Cited by 294
The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
van der Bij, A. K., & Pitout, J. D. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks214 · Cited by 292
Ruppé, E., Armand-Lefèvre, L., Estellat, C., Consigny, P.-H., El Mniai, A., Boussadia, Y., Goujon, C., Ralaimazava, P., Campa, P., Girard, P.-M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ333 · Cited by 278
Bartlett, J. G. (2004) · Infectious Diseases in Clinical Practice · Cited by 266
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Doi, Y., Iovleva, A., & Bonomo, R. A. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/taw102 · Cited by 248
Laupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M., & Pitout, J. D. D. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.034 · Cited by 238
‘Disperse abroad in the land’: the role of wildlife in the dissemination of antimicrobial resistance
Arnold, K. E., Williams, N. J., & Bennett, M. (2016) · Biology Letters · doi:10.1098/rsbl.2016.0137 · Cited by 237
Fernandes, M. R., Moura, Q., Sartori, L., Silva, K. C., Cunha, M. P., Esposito, F., Lopes, R., Otutumi, L. K., Gonçalves, D. D., Dropa, M., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.17.30214 · Cited by 232
Bank, W. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/26707 · Cited by 228
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
Lipsitch, M., & Siber, G. R. (2016) · mBio · doi:10.1128/mbio.00428-16 · Cited by 225
Diekema, D. J., Pfaller, M. A., Shortridge, D., Zervos, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy270 · Cited by 221
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States
Bartsch, S. M., McKinnell, J. A., Mueller, L. E., Miller, L. G., Gohil, S. K., Huang, S. S., & Lee, B. Y. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.003 · Cited by 220
National campaigns to improve antibiotic use
Goossens, H., Guillemot, D., Ferech, M., Schlemmer, B., Costers, M., van Breda, M., Baker, L. J., Cars, O., & Davey, P. G. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0094-7 · Cited by 211
Lübbert, C., Straube, L., Stein, C., Makarewicz, O., Schubert, S., Mössner, J., Pletz, M. W., & Rodloff, A. C. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.12.001 · Cited by 204
Global travel patterns: an overview
Glaesser, D., Kester, J., Paulose, H., Alizadeh, A., & Valentin, B. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax007 · Cited by 204
(2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1511 · Cited by 202
Trends in fluoroquinolone resistance in Campylobacter
Sproston, E. L., Wimalarathna, H. M. L., & Sheppard, S. K. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000198 · Cited by 192
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
Carrel, M., Perencevich, E. N., & David, M. Z. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.150452 · Cited by 185
Understanding drivers of antibiotic resistance genes in High Arctic soil ecosystems
McCann, C. M., Christgen, B., Roberts, J. A., Su, J.-Q., Arnold, K. E., Gray, N. D., Zhu, Y.-G., & Graham, D. W. (2019) · Environment International · doi:10.1016/j.envint.2019.01.034 · Cited by 184
Östholm-Balkhed, Å., Tärnberg, M., Nilsson, M., Nilsson, L. E., Hanberger, H., Hällgren, A., & on behalf of the Travel Study Group of Southeast Sweden (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt167 · Cited by 177
Global spread of New Delhi metallo-β-lactamase 1
Hammerum, A. M., Toleman, M. A., Hansen, F., Kristensen, B., Lester, C. H., Walsh, T. R., & Fuursted, K. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70276-0 · Cited by 173
Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8
Strauß, L., Stegger, M., Akpaka, P. E., Alabi, A. S., Breurec, S., Coombs, G. W., Egyir, B., Larsen, A. R., Laurent, F. J., Monecke, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702472114 · Cited by 172
Diekema, D. J., Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Tendolkar, S., McDanel, J. S., & Doern, G. V. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/675283 · Cited by 163
Ready-to-Eat Shrimp as an International Vehicle of Antibiotic-Resistant Bacteria
Durán, G. M., & Marshall, D. L. (2005) · Journal of Food Protection · doi:10.4315/0362-028x-68.11.2395 · Cited by 158
Al‐Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.415 · Cited by 147
Self-citationVancomycin-resistant enterococci: 15 years and counting
Chavers, L. S., Moser, S. A., Benjamin, W. H., Banks, S., Steinhauer, J. R., Smith, A. M., Johnson, C. N., Funkhouser, E. M., Chavers, L. P., Stamm, A. M., et al. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1375 · Cited by 146
Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, Tunisia, July 2015
Grami, R., Mansour, W., Mehri, W., Bouallègue, O., Boujâafar, N., Madec, J.-Y., & Haenni, M. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.8.30144 · Cited by 145
Kuenzli, E., Jaeger, V. K., Frei, R., Neumayr, A. L. C., DeCrom, S., Haller, S., Blum, J. A., Widmer, A. F., Furrer, H., Battegay, M., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-528 · Cited by 142
Woerther, P.-L., Andremont, A., & Kantele, A. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/taw101 · Cited by 142
(2001) · PubMed · Cited by 141
Life After USA300: The Rise and Fall of a Superbug
Planet, P. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw444 · Cited by 140
Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid.1908.130257 · Cited by 138
Urbaniak, C., Sielaff, A. C., Frey, K. G., Allen, J., Singh, N. K., Jaing, C. J., Wheeler, K. A., & Venkateswaran, K. J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18506-4 · Cited by 137
Antimicrobial stewardship in Australian hospitals
Duguid, M. J., & Cruickshank, M. (2011) · Cited by 134
Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1908.130257 · Cited by 133
Glaser, P., Martins-Simões, P., Villain, A., Barbier, M., Tristan, A., Bouchier, C., Ma, L., Bes, M., Laurent, F. J., Guillemot, D., et al. (2016) · mBio · doi:10.1128/mbio.02183-15 · Cited by 129
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010.
(2010) · PubMed · Cited by 124
Rotimi, V. O., Jamal, W. Y., Pál, T., Sovenned, A., & Albert, M. J. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47509-0 · Cited by 120
Travel and the Spread of Drug-Resistant Bacteria
Schwartz, K. L., & Morris, S. K. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0634-9 · Cited by 115
Petersen, T. N., Rasmussen, S., Hasman, H., Carøe, C., Bælum, J., Schultz, A. C., Bergmark, L., Svendsen, C. A., Lund, O., Sicheritz‐Pontén, T., et al. (2015) · Scientific Reports · doi:10.1038/srep11444 · Cited by 112
WHO Global Antimicrobial Resistance Surveillance System early implementation 2016–17
Tornimbene, B., Eremin, S., Escher, M., Griskeviciene, J., Manglani, S., & Pessoa-Silva, C. L. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30060-4 · Cited by 107
Geissler, A. L., Carrillo, F. A. B., Swanson, K. C., Patrick, M. E., Fullerton, K. E., Bennett, C., Barrett, K., & Mahon, B. E. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix624 · Cited by 97
Bernasconi, O. J., Kuenzli, E., Pires, J., Tinguely, R., Carattoli, A., Hatz, C., Perreten, V., & Endimiani, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00731-16 · Cited by 96
Self-citationCody, A. J., McCarthy, N. D., Wimalarathna, H. M. L., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01086-12 · Cited by 95
International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review
Hassing, R. J., Alsma, J., Arcilla, M. S., van Genderen, P. J. J., Stricker, B. H. C., & Verbon, A. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.47.30074 · Cited by 94
Barbier, F., Pommier, C., Essaied, W. I., Garrouste-Orgeas, M., Schwebel, C., Ruckly, S., Dumenil, A.-S., Lemiale, V., Mourvillier, B., Clec’h, C., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv423 · Cited by 89
The Gathering Storm: Is Untreatable Typhoid Fever on the Way?
Levine, M. M., & Simon, R. (2018) · mBio · doi:10.1128/mbio.00482-18 · Cited by 89
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Jain, A., Hopkins, K. L., Turton, J. F., Doumith, M., Hill, R., Loy, R., Meunier, D., Pike, R., Livermore, D. M., & Woodford, N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku084 · Cited by 87
Lin, D., Chen, K., Chan, E. W., & Chen, S. (2015) · Scientific Reports · doi:10.1038/srep14754 · Cited by 82
Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update
Ruppé, É., Andremont, A., & Armand-Lefèvre, L. (2017) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2017.11.007 · Cited by 81
Shibuya, Y., Hara, M., Higuchi, W., Takano, T., Iwao, Y., & Yamamoto, T. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0640-1 · Cited by 78
Group A Streptococcus emm Gene Types in Pharyngeal Isolates, Ontario, Canada, 2002–2010
Shea, P. R., Ewbank, A. L., Gonzalez-Lugo, J. H., Martagón, A. J., Martínez-Gutiérrez, J. C., Rehman, H., Gonzalez, M. S., Fittipaldi, N., Beres, S. B., Flores, A. R., et al. (2011) · Emerging infectious diseases · doi:10.3201/eid1711.110159 · Cited by 77
Tribble, D. R. (2016) · Journal of Travel Medicine · doi:10.1093/jtm/taw090 · Cited by 76
NDM-1 and the Role of Travel in Its Dissemination
Wilson, M. E., & Chen, L. H. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0252-x · Cited by 74
Weisenberg, S. A., Mediavilla, J. R., Chen, L., Alexander, E. L., Rhee, K. Y., Kreiswirth, B. N., & Jenkins, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045141 · Cited by 73
Frequent acquisition of low-virulence strains of ESBL-producingEscherichia coliin travellers
Vading, M., Kabir, M. H., Kalin, M., Iversen, A., Wiklund, S., Nauclér, P., & Giske, C. G. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw335 · Cited by 72
von Wintersdorff, C. J. H., Wolffs, P. F. G., van Niekerk, J. M., Beuken, E. V. H., van Alphen, L. B., Stobberingh, E. E., Lashof, A. M. L. O., Hoebe, C. J. P. A., Savelkoul, P. H. M., & Penders, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw328 · Cited by 72
Williamson, D. A., Lane, C. R., Easton, M., Valcanis, M., Strachan, J., Veitch, M., Kirk, M., & Howden, B. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02012-17 · Cited by 70
Wang, S., Welsh, L. R. J., Thorpe, P., Whisson, S. C., Boevink, P. C., & Birch, P. R. J. (2018) · mBio · doi:10.1128/mbio.01216-18 · Cited by 67
The Role of International Travel in the Spread of Methicillin‐Resistant Staphylococcus aureus
Zhou, Y. P., Wilder‐Smith, A., & Hsu, L. Y. (2014) · Journal of Travel Medicine · doi:10.1111/jtm.12133 · Cited by 66
Otter, J. A., Havill, N. L., Boyce, J. M., & French, G. L. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0698-9 · Cited by 66
Kempker, R. R., Farley, M. M., Ladson, J., Satola, S. W., & Ray, S. M. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.09.021 · Cited by 66
Epelboin, L., Robert, J., Tsyrina-Kouyoumdjian, E., Laouira, S., Meyssonnier, V., Caumes, É., & The MDR-GNB Travel Working Group (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12211 · Cited by 64
Cheah, Y. K., Learn-Han, L., Noorzaleha, A. S., Son, R., Sabrina, S., Sim, J.-H., & Chai-Hoon, K. (2008) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02311.x · Cited by 61
Post, A. S., Martiny, D., van Waterschoot, N., Hallin, M., Maniewski, U., Bottieau, E., Esbroeck, M. V., Vlieghe, E., Ombelet, S., Vandenberg, O., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3032-6 · Cited by 60
Kantele, A., Mero, S., Kirveskari, J. P., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.151272 · Cited by 59
Challagundla, L., Luo, X., Tickler, I. A., Didelot, X., Coleman, D. C., Shore, A. C., Coombs, G. W., Sordelli, D. O., Brown, E. L., Skov, R. L., et al. (2018) · mBio · doi:10.1128/mbio.02016-17 · Cited by 57
Jansen, W., Müller, A., Grabowski, N. T., Kehrenberg, C., Muylkens, B., & Dahouk, S. A. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.12.009 · Cited by 53
Chan, H. L. E., Poon, L. M., Chan, S. G., & Teo, J. W. P. (2011) · PubMed · Cited by 45
Toleman, M. S., Reuter, S., Coll, F., Harrison, E. M., Blane, B., Brown, N. M., Török, M. E., Parkhill, J., & Peacock, S. J. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw166 · Cited by 42
Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem
Yadav, G. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/27260.10474 · Cited by 42
Ciprofloxacin-resistant campylobacteriosis in the UK
Cody, A. J., Clarke, L. A., Bowler, I. C. J. W., & Dingle, K. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62261-1 · Cited by 37
Bevan, E. R., McNally, A., Thomas, C. M., Piddock, L. J. V., & Hawkey, P. M. (2018) · mBio · doi:10.1128/mbio.02408-18 · Cited by 37
Angue, M., Allou, N., Belmonte, O., Lefort, Y., Lugagne, N., Vandroux, D., Montravers, P., & Allyn, J. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12220 · Cited by 34
Mason, C. J., Sornsakrin, S., Seidman, J. C., Srijan, A., Serichantalergs, O., Thongsen, N., Ellis, M. W., Ngauy, V., Swierczewski, B., & Bodhidatta, L. (2017) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-017-0056-y · Cited by 32
Valverde, A., Turrientes, M. C., Norman, F., Martín, E. S., Moreno, L., Pérez-Molina, J. A., López‐Vélez, R., & Cantón, R. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.09.021 · Cited by 31
de Almeida, M. V. A., Cangussú, Í. M., de Carvalho, A. L. S., Brito, I. L. P., & Costa, R. A. (2017) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201759070 · Cited by 30
Koch, K., Kristensen, B., Holt, H. M., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-277 · Cited by 21
Gaudreau, C., Boucher, F., Gilbert, H., & Békal, S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00362-14 · Cited by 19
Romero-Álvarez, D., Reyes, J., Quezada, V., Satán, C., Cevallos, N., Barrera, S., Trueba, G. A., Escobar, L. E., & Villacís, J. E. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.10.012 · Cited by 18
Nair, R., Ammann, E. M., Rysavy, M. A., & Schweizer, M. L. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/674385 · Cited by 17
Gottlieb, T., Su, W., Merlino, J., & Cheong, E. Y. L. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01962.x · Cited by 17
HUANG, X.-Z., Cash, D. M., Chahine, M. A., HORN, G. T. V., Erwin, D. P., McKay, J., HAMILTON, L. R., Jerke, K. H., CO, E.-M. A., Aldous, W. K., et al. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810001950 · Cited by 15
Antibiotic resistance in travellers’ diarrhoeal disease, an external perspective
Hitch, G., & Fleming, N. (2018) · Journal of Travel Medicine · doi:10.1093/jtm/tay014 · Cited by 15
Dave, J., Warburton, F. G., Freedman, J., de Pinna, E., Grant, K., Sefton, A. M., Crawley-Boevey, E., Godbole, G., Holliman, R. E., & Balasegaram, S. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000484 · Cited by 9
Condom use among Swedes while traveling internationally: A qualitative descriptive study
Lejelind, E., Westerling, R., Fugl-Meyer, K. S., & Larsson, K. (2017) · Nursing and Health Sciences · doi:10.1111/nhs.12341 · Cited by 6
Cited by
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
“By being exposed to resistant pathogens, human travelers are highly likely to return colonized and infected to their country.(39) For instance, Ruppe et al have shown that European tourists traveling to India who had absolutely no contact with the Indian health care system still tested positive for carbapenemaseproduc…”
BackgroundAntimicrobial resistance: a concise update
Ho, C. S., Wong, C. T. H., Aung, T. T., Lakshminarayanan, R., Mehta, J. S., Rauz, S., McNally, A., Kintses, B., Peacock, S. J., de la Fuente-Nunez, C., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.010 · Cited by 634
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., Islam, T., Islam, S., & Haque, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.535668 · Cited by 329
Metadata
- Authors
- Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R.
- Venue
- Journal of Travel Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019
- Volume
- 26
- Issue
- 8
- ISSN
- 1195-1982 (ISSN-L)
- 1708-8305
- OpenAlex
- W2945154194
- Cited by
- 338
- References
- 123
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.